United StatesBreaking News

Lombard Odier's Homin Lee lays out potential outcomes for investors as the Strait of Hormuz remains closed and economies around the world remain exposed to higher oil prices.

Elisa Ewers, Senior Fellow for Middle East Studies at the Council on Foreign Relations, discusses the latest developments on the Iran war as President Trump insisted that freedom of navigation through the Strait of Hormuz be part of any deal. She speaks with Paul Allen and Shery Ahn on Bloomberg: The Asia Trade.

President Donald Trump has insisted that freedom of navigation through the Strait of Hormuz be part of any deal and escalated threats to obliterate key Iranian infrastructure. Bloomberg's Laura Davison reports.

GoPro (NASDAQ:GPRO) announced on April 7, 2026, that its Board of Directors has approved a comprehensive restructuring plan designed to significantly reduce operating costs and accelerate the company’s push toward stronger operating leverage.

Skillsoft (NYSE:SKIL), a global leader in corporate digital learning and skills management, reported its financial results for the fourth quarter and full fiscal year ended January 31, 2026, on April 7, 2026.

SolarMax Technology (NASDAQ:SMXT), a leading integrated solar energy company, announced record financial results for the fiscal year ended December 31, 2025, marked by a near-fourfold increase in revenue and a significant expansion of its energy storage pipeline.

Lexaria Bioscience (NASDAQ:LEXX), a global innovator in drug delivery platforms, issued a statement on April 7, 2026, applauding the U.S. Food and Drug Administration (FDA) approval of Eli Lilly’s Foundayo, the latest oral GLP-1 receptor agonist for chronic weight management in adults.

TransDigm Group (NYSE:TDG), a leading global designer, producer, and supplier of highly engineered aircraft components, announced on April 7, 2026, the successful completion of its acquisition of Jet Parts Engineering and Victor Sierra Aviation Holdings for approximately $2.2 billion in cash.

Savara (NASDAQ:SVRA), a clinical-stage biopharmaceutical company dedicated to rare respiratory diseases, announced on April 7, 2026, that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has accepted its Marketing Authorisation Application (MAA) for MOLBREEVI.

Fluor (NYSE:FLR) announced on April 7, 2026, that it has been selected by America First Refining (AFR) to execute the front-end engineering and design (FEED) for a landmark large-scale refining facility in Brownsville, Texas.

Gilead Sciences (NASDAQ:GILD) announced on April 7, 2026, that it has entered into a definitive agreement to acquire Tubulis GmbH, a private German biotechnology company specializing in next-generation antibody-drug conjugates (ADCs).

Jaguar Health (NASDAQ:JAGX), a commercial-stage pharmaceutical company focused on gastrointestinal products, released its consolidated financial results for the fourth quarter and full year ended December 31, 2025, on April 7, 2026.